NARCOLEPSY TREATMENT

Japan's Takeda Pharma to restructure after annual profit slump

​Japan's biggest drugmaker said it will incur restructuring costs of about 140 billion yen ($899 million) this fiscal year as part of a plan to optimise its workforce, cut costs and strengthen technology.